ONO-8590580 is a GABAA α5 negative allosteric modulator.
For research use only. We do not sell to patients.
| Name | ONO-8590580 |
|---|---|
| Iupac Chemical Name | 3-(cyclopropylmethyl)-6-fluoro-7-methyl-N-[5-(1-methylimidazol-4-yl)pyridin-2-yl]benzimidazol-5-amine |
| Synonyms | ONO-8590580;GTPL9908;SCHEMBL16972807 |
| Molecular Formula | C21H21FN6 |
| Molecular Weight | 376.43 |
| Smile | CC1=C2C(=CC(=C1F)NC3=NC=C(C=C3)C4=CN(C=N4)C)N(C=N2)CC5CC5 |
| InChiKey | INGJMHPGMVUEKY-UHFFFAOYSA-N |
| InChi | InChI=1S/C21H21FN6/c1-13-20(22)16(7-18-21(13)25-12-28(18)9-14-3-4-14)26-19-6-5-15(8-23-19)17-10-27(2)11-24-17/h5-8,10-12,14H,3-4,9H2,1-2H3,(H,23,26) |
| CAS Number | 1802661-73-9 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |